{{Rsnum
|rsid=1800893
|Gene=IL10
|Chromosome=1
|position=206773822
|Orientation=minus
|GMAF=0.3108
|Gene_s=IL10
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 27.4 | 51.3 | 21.2
| HCB | 0.0 | 9.5 | 90.5
| JPT | 0.9 | 8.0 | 91.2
| YRI | 11.6 | 37.4 | 51.0
| ASW | 14.0 | 45.6 | 40.4
| CHB | 0.0 | 9.5 | 90.5
| CHD | 0.0 | 11.9 | 88.1
| GIH | 7.9 | 39.6 | 52.5
| LWK | 16.5 | 49.5 | 33.9
| MEX | 10.3 | 43.1 | 46.6
| MKK | 18.6 | 58.3 | 23.1
| TSI | 26.5 | 36.3 | 37.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=23148667
|Title=The SNP at -592 of human IL-10 gene is associated with serum IL-10 levels and increased risk for human papillomavirus cervical lesion development
|OA=1
}}

{{PMID Auto
|PMID=16600026
|Title=Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway.
|OA=1
}}

{{PMID Auto
|PMID=16672419
|Title=Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation.
|OA=1
}}

{{PMID Auto
|PMID=17215862
|Title=The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma.
}}

{{PMID Auto
|PMID=18479293
|Title=Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}